Cargando…

Development of a surrogate potency assay to determine the angiogenic activity of Stempeucel®, a pooled, ex-vivo expanded, allogeneic human bone marrow mesenchymal stromal cell product

BACKGROUND: Mesenchymal stromal cells (MSCs) have emerged as a more beneficial alternative to conventional therapy and may offer a potential cure for unmet medical needs. MSCs are known to possess strong immunomodulatory and anti-inflammatory properties. Moreover, they promote angiogenesis and tissu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thej, Charan, Ramadasse, Balamurugan, Walvekar, Ankita, Majumdar, Anish S., Balasubramanian, Sudha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331748/ https://www.ncbi.nlm.nih.gov/pubmed/28245882 http://dx.doi.org/10.1186/s13287-017-0488-3

Ejemplares similares

Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint
por: Gupta, Pawan Kumar, et al.
Publicado: (2016)

Human bone marrow-derived, pooled, allogeneic mesenchymal stromal cells manufactured from multiple donors at different times show comparable biological functions in vitro, and in vivo to repair limb ischemia
por: Thej, Charan, et al.
Publicado: (2021)

StemOne(TM)/Stempeucel(®): CDSCO Approved, Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogenic Mesenchymal Stem Cells for Knee Osteoarthritis
por: Gupta, Ashim
Publicado: (2023)

Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease
por: Gupta, Pawan Kumar, et al.
Publicado: (2021)

Administration of Adult Human Bone Marrow‐Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger’s Disease: Phase II Study Report Suggests Clinical Efficacy
por: Gupta, Pawan K., et al.
Publicado: (2016)

Preclinical safety & toxicity evaluation of pooled, allogeneic human bone marrow-derived mesenchymal stromal cells
por: Rengasamy, Mathiyazhagan, et al.
Publicado: (2016)

Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton’s jelly derived mesenchymal stem cells? A comparative study
por: Swamynathan, Priyanka, et al.
Publicado: (2014)

Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton’s jelly mesenchymal stromal cells
por: Rengasamy, Mathiyazhagan, et al.
Publicado: (2017)

Surrogate potency assays: Comparison of binding profiles complements dose response curves for unambiguous assessment of relative potencies
por: Karlsson, Robert, et al.
Publicado: (2018)

Unfathomed Nanomessages to the Heart: Translational Implications of Stem Cell-Derived, Progenitor Cell Exosomes in Cardiac Repair and Regeneration
por: Thej, Charan, et al.
Publicado: (2021)

Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease
por: Gupta, Pawan Kumar, et al.
Publicado: (2023)

An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells
por: Lieberman, Nicole A. P., et al.
Publicado: (2018)

Isolation, characterization, and gene expression analysis of Wharton’s jelly-derived mesenchymal stem cells under xeno-free culture conditions
por: Venugopal, Parvathy, et al.
Publicado: (2011)

Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis
por: Yamaguchi, Yukie, et al.
Publicado: (2010)

Ex Vivo Modeling of Human Neuroendocrine Tumors in Tissue Surrogates
por: Herring, Brendon, et al.
Publicado: (2021)

Comparing the angiogenic potency of naïve marrow stromal cells and Notch-transfected marrow stromal cells
por: Dao, Mo, et al.
Publicado: (2013)

Angiogenic potency evaluation of cell therapy candidates by a novel application of the in vitro aortic ring assay
por: Iqbal, Farwah, et al.
Publicado: (2017)

Prevention of Allogeneic Cardiac Graft Rejection by Transfer of Ex Vivo Expanded Antigen-Specific Regulatory T-Cells
por: Takasato, Fumika, et al.
Publicado: (2014)

Dynamics of Ex Vivo Mesenchymal Stromal Cell Potency under Continuous Perfusion
por: Doshi, Aneesha, et al.
Publicado: (2023)

Near-infrared photoactive Ag-Zn-Ga-S-Se quantum dots for high-performance quantum dot-sensitized solar cells
por: Kottayi, Roopakala, et al.
Publicado: (2022)

Allogeneic Ex Vivo Expanded Corneal Epithelial Stem Cell Transplantation: A Randomized Controlled Clinical Trial
por: Campbell, John D.M., et al.
Publicado: (2019)

An Ex Vivo Model for Anti-Angiogenic Drug Testing on Intact Microvascular Networks
por: Azimi, Mohammad S., et al.
Publicado: (2015)

Genetic Modifications That Expand Oncolytic Virus Potency
por: Cristi, Francisca, et al.
Publicado: (2022)

Ex-vivo partial nephrectomy after living donor nephrectomy: Surgical technique for expanding kidney donor pool
por: Nyame, Yaw A., et al.
Publicado: (2017)

Reduction of metastatic and angiogenic potency of malignant cancer by Eupatorium fortunei via suppression of MMP-9 activity and VEGF production
por: Kim, Aeyung, et al.
Publicado: (2014)

SURROGATE SELECTION OVERSAMPLES EXPANDED T CELL CLONOTYPES
por: Yu, Peng, et al.
Publicado: (2023)

An ex vivo human cartilage repair model to evaluate the potency of a cartilage cell transplant
por: Bartz, Christoph, et al.
Publicado: (2016)

Atherosclerotic Pre-Conditioning Affects the Paracrine Role of Circulating Angiogenic Cells Ex-Vivo
por: Eslava-Alcon, Sara, et al.
Publicado: (2020)

Relative potency of xenobiotic estrogens in an acute in vivo mammalian assay.
por: Milligan, S R, et al.
Publicado: (1998)

PSMA‐positive membranes secreted from prostate cancer cells have potency to transform vascular endothelial cells into an angiogenic state
por: Watanabe, Ryuta, et al.
Publicado: (2021)

Design, synthesis and evaluation of dihydro-1H-indene derivatives as novel tubulin polymerisation inhibitors with anti-angiogenic and antitumor potency
por: Xu, Shengtao, et al.
Publicado: (2023)

Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19
por: Ahmadvand, Mohammad, et al.
Publicado: (2023)

Biomarkers as Surrogates for Coronary Endothelial Dysfunction in Patients With Nonobstructive Coronary Artery Disease
por: Vani, Anish, et al.
Publicado: (2018)

Small molecules enhance the potency of natural antimicrobial peptides
por: Losasso, Valeria, et al.
Publicado: (2022)

Pre-screening the intrinsic angiogenic capacity of biomaterials in an optimised ex ovo chorioallantoic membrane model
por: Kohli, Nupur, et al.
Publicado: (2020)

The Role of Anti-Angiogenics in Pre-Treated Metastatic BRAF-Mutant Colorectal Cancer: A Pooled Analysis
por: Gelsomino, Fabio, et al.
Publicado: (2020)

MSC Transplantation Attenuates Inflammation, Prevents Endothelial Damage and Enhances the Angiogenic Potency of Endogenous MSCs in a Model of Pulmonary Arterial Hypertension
por: Shao, Fengjin, et al.
Publicado: (2022)

A Comparison of Ex Vivo Expanded Human Regulatory T Cells Using Allogeneic Stimulated B Cells or Monocyte-Derived Dendritic Cells
por: Lee, Linda M., et al.
Publicado: (2021)

Ex Vivo Lung Perfusion – State of the Art in Lung Donor Pool Expansion
por: Popov, Aron-Frederik, et al.
Publicado: (2015)

Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms
por: Harper, Michael S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9jre0r3kod3cvmlrmkkd62dsnj